Aspire Biopharma Holdings, Inc. (ASBP)
9.00
+0.39
(+4.53%)
USD |
NASDAQ |
Sep 10, 14:41
Aspire Biopharma Holdings Shareholders Equity (Quarterly) : 11.76M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 11.76M |
| March 31, 2026 | 3.868M |
| December 31, 2025 | -6.376M |
| September 30, 2025 | -11.47M |
| June 30, 2025 | -9.617M |
| March 31, 2025 | -6.953M |
| December 31, 2024 | -1.540M |
| September 30, 2024 | 0.0903M |
| June 30, 2024 | 0.6273M |
| March 31, 2024 | 17.57M |
| Date | Value |
|---|---|
| December 31, 2023 | 19.58M |
| September 30, 2023 | 19.58M |
| June 30, 2023 | 20.28M |
| March 31, 2023 | 291.94M |
| December 31, 2022 | 289.07M |
| September 30, 2022 | 286.84M |
| June 30, 2022 | 285.76M |
| March 31, 2022 | 285.64M |
| December 31, 2021 | -0.0005M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Resonate Blends, Inc. | -5.364M |
| Breakthrough Chemistry, Inc. | 0.8373M |
| Kaya Holdings, Inc. | -0.5474M |
| Cardiac Biotech Solutions, Inc. | -2.221M |
| Endexx Corp. | -31.85M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.54M |
| Total Liabilities (Quarterly) | 1.783M |
| Current Ratio | 7.986 |
| Net Debt Paydown Yield | 19.56% |